• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

ZEG Berlin GmbH

Zentrum für Epidemiologie und Gesundheitsforschung

  • Home
  • Expertise
    • Real-World Evidence
    • Non-interventional study design
    • Post-authorization safety studies
    • Post-authorization efficacy studies
    • Cohort studies
    • Case-control studies
    • Medical Devices
    • Data collection instruments
  • Services
    • RWE Services
    • Crisis Management
    • Consulting
    • Data Management and Biostatistics
    • Medical Writing
    • Study Management
    • Quality Assurance
    • Pharmacovigilance
  • Library & News
    • News/Conferences
    • Publications
  • PROs
    • Menopause Rating Scale
      • Menopause Rating Scale (MRS) – Languages
    • Aging Male Symptoms Scale
      • AMS – properties as an outcome measure
      • AMS – properties as a screening tool
    • Quality of Sexual Function Scale
      • Quality of Sexual Function Scale
    • Short Term Hormone Effect Scale
      • Short Term Hormone Effect Scale
    • Research team
  • About Us
    • Who We Are
      • Management Board
      • Executive Team
      • Project Management Team
    • History
    • Careers
    • Data Protection Information
  • Contact

Publications

Dinger Jürgen, Assmann Anita, The safety of HRT under real life conditions: interim results from the EURAS HRT study. Gynecol Endocrinol. 2008; 24: S51.
Raff T, Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, The risk of uterine and ovarian cancer for different formulations of hormone therapy (HT). The Open Epidemiology Journal. 2008; 1:17-25.
Behre H M, Heinemann Lothar A , Morales A, Pexman-Fieth C, Rationale, design and methods of the esprit study: energy, sexual desire and body proportions with AndroGel, Testosterone 1% gel therapy, in hypogonadal men. The Aging Male. 2008; 11:101-106.
Heinemann Lothar A , Damonte Khoury C, Assessment of the impact of severe premenstrual disorders on work absenteeism and productivity. 10th Congress of the European Society of Contraception. 2008; Prague, April 30 - May 3 2008.
Michielsen P, Heinemann Lothar A , Mihatsch M, Schnülle P, Graf H, Koch KM, Non-phenacetin analgesics and analgesic nephropathy: Clinical assessment of high users from a case-control study. NDT Advance Access. 2008; doi:10.1093/ndt/gfn643.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, No increased risk of colon cancer associated with various HRT formulations: a case-control study BMC Cancer. 2007; 7:76. doi:10.1186/1471-2407-7-76.
Heinemann Lothar A , Dinger Jürgen, Range of published estimates of VTE incidence in young women Contraception. 2007; 75: 3328-336.
Dinger Jürgen, Heinemann Lothar A , Kuehl-Habich D, The safety of a drospirenone-containing oral contraceptive: Final results from the European Active Surveillance study on Oral Contraceptives (EURAS-OC) based on 142,475 women-years of observation Contraception. 2007; DOI: 10.1016/j.contraception.2006.12.019.
Heinemann Lothar A , HPG – initiator & facilitator: the Menopause Rating Scale (MRS). HPG Schneider (Ed) Ein Vierteljahhundert Frauenheilkunde und Gebortshilfe aus Münsteraner Sicht. Hanser & Co GmbH, Münster. 2007; p. 198-203.
Dinger Jürgen, Heinemann Lothar A , Do Minh Thai, Assmann Anita, Colon cancer risk and different HRT formulations: a case-control study. BMC Cancer. 2007; 8;7:76.
Dinger Jürgen, Heinemann Lothar A , Westhoff C, Final results from the EURAS study: impact of oral contraception on public health. Obstet Gynecol. 2007; 109(4): 5S.
Dinger Jürgen, Heinemann Lothar A , Westhoff C, First results from the international active surveillance study on oral contraceptives (INAS-OC). Obstet Gynecol. 2007; 109(4): 58S.
  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • Interim pages omitted …
  • Page 22
  • Go to Next Page »

sidebar

Search our Publications

sidebar-alt

Footer

ZEG Berlin

Berlin Center for Epidemiology and Health Research

Invalidenstraße 115
10115 Berlin
Germany

Contact Us

Expertise

  • Real-World Evidence
  • Non-interventional study design
  • Post-authorization safety studies
  • Post-authorization efficacy studies
  • Cohort studies
  • Case-control studies
  • Medical Devices
  • Patient Reported Outcomes (PROs)
  • Data collection instruments

Services

  • Crisis Management
  • Consulting
  • Data Management and Biostatistics
  • Medical Writing
  • Study Management
  • Quality Assurance
  • Pharmacovigilance

ENCePP

We are a partner centre of the ENCePP scientific network which is coordinated by the European Medicines Agency. We are dedicated to excellence in research by adhering to the ENCePP Guide on Methodological Standards and promoting scientific independence and transparency. We register studies in the ENCePP E-Register of Studies, a publicly accessible resource for the registration of pharmacoepidemiological and pharmacovigilance studies.

General Data Protection Regulation

With a view to the introduction of the GDPR/EUDSGVO we are glad to present our newupdated privacy policy . The updated description are stored under “about us” and then “privacy policy/GDPR”. Further translation for study participants will follow contemporary.

© 2011–2025 ZEG Berlin

Impressum

Website by Laura Yeffeth.